Document ID: chunk:federal_register_of_legislation:F2024L00486:reg:9
Version: federal_register_of_legislation:F2024L00486
Segment Type: reg
Provision Reference: reg 9
Character Range: 4286–6284

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant melanoma of the skin or death from malignant melanoma of the skin is connected with the circumstances of a person's relevant service:
(1)          having at least 5 sunburns at the affected site at least 5 years before clinical onset;
Note: sunburn is defined in the Schedule 1 - Dictionary.
(2)          having sunlight exposure to unprotected skin for a cumulative period of at least 4,500 latitude equivalent hours before clinical onset;
Note: latitude equivalent hours and unprotected skin are defined in the Schedule 1 - Dictionary.
(3)          having ultraviolet radiation exposure from an ultraviolet-emitting tanning device on at least 10 occasions before the clinical onset of malignant melanoma of the skin, where the first exposure occurred more than 5 years before clinical onset;
(4)           having PUVA therapy, where:
(a)          the first PUVA treatment commenced at least 15 years before clinical onset; and
(b)          at least 250 PUVA treatments were administered, before clinical onset;
Note: PUVA therapy is defined in the Schedule 1 - Dictionary.
(5)          undergoing solid organ (excluding corneal transplant) or bone marrow transplantation before clinical onset;
(6)          being treated with methotrexate or azathioprine within the 2 years before clinical onset;
(7)          having non-Hodgkin lymphoma at least one year before clinical onset;
(8)          having chronic lymphocytic leukaemia/small cell lymphoma at least one year before clinical onset;
Note: Chronic lymphocytic leukaemia/small cell lymphoma is also known as mature B-cell lymphoid leukaemia and small lymphocytic lymphoma.
(9)          having Parkinson's disease for at least 2 years before clinical onset;
(10)      inability to obtain appropriate clinical management for malignant melanoma of the skin before clinical worsening.